Summit Therapeutics
SMMT
NZ$33.06
Share price
-1.91%
Change (1 day)
160.25%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: NZ$24.55 Billion
As of June 2025 Summit Therapeutics has a market cap of NZ$24.55 Billion. This makes Summit Therapeutics the world's 1313th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$24.55 B | 3.12% |
| 2024 | NZ$23.81 B | 723.22% |
| 2023 | NZ$2.89 B | 114.63% |
| 2022 | NZ$1.34 B | 250.19% |
| 2021 | NZ$0.38 B | -28.18% |
| 2020 | NZ$0.53 B | 235.74% |
| 2019 | NZ$0.15 B | 465.79% |
| 2018 | NZ$28.2 M | -87.89% |
| 2017 | NZ$0.23 B | 53.24% |
| 2016 | NZ$0.15 B | -26.22% |
| 2015 | NZ$0.20 B |
End of Day market cap according to different sources
On Jun 19th, 2025 the market cap of Summit Therapeutics was reported to be:
N/A
NZ$25.03 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | NZ$3.30 B | -86.54% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | NZ$10.30 B | -58.02% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | NZ$0.37 B | -98.48% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | NZ$0.14 B | -99.41% | 🇺🇸 USA |